Publications by authors named "Shuping Dou"

Claim this Profile
C
Comparison of microendoscopic discectomy and open discectomy for single-segment lumbar disc herniation.
Jiu-Ya Pang, Fei Tan, Wei-Wei Chen, Cui-Hua Li, Shu-Ping Dou

World J Clin Cases· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of Klebsiella. Pneumoniae Infection with an Antisense Oligomer Against its Ribosomal RNA.
Ling Chen, Dengfeng Cheng, Guozheng Liu, Shuping Dou, Yuzhen Wang

Mol Imaging Biol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel DNA Polymer for Amplification Pretargeting.
Xiao Li, Qingqing Huang, Jie Xiao, Guozheng Liu, Shuping Dou

ACS Med Chem Lett· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative Correlation of in Vivo Properties with in Vitro Assay Results: The in Vitro Binding of a Biotin-DNA Analogue Modifier with Streptavidin Predicts the in Vivo Avidin-Induced Clearability of the Analogue-Modified Antibody.
Shuping Dou, John Virostko, Dale L Greiner, Alvin C Powers, Guozheng Liu

Mol Pharm· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A feasible approach to evaluate the relative reactivity of NHS-ester activated group with primary amine-derivatized DNA analogue and non-derivatized impurity.
Shuping Dou, John Virostko, Dale L Greiner, Alvin C Powers, Guozheng Liu

Nucleosides Nucleotides Nucleic Acids· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differentiation between temporary and real non-clearability of biotinylated IgG antibody by avidin in mice.
Shuping Dou, John Virostko, Mary Rusckowski, Dale L Greiner, Alvin C Powers

Front Pharmacol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison between two labeled agents in mice using a coinjection-ratio approach in contrast to a conventional group approach.
Shuping Dou, Yuzhen Wang, Bruce Barton, Ling Chen, Mary Rusckowski

Nucl Med Biol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
(
(99m)Tc-MORF oligomers specific for bacterial ribosomal RNA as potential specific infection imaging agents.
Ling Chen, Yi Wang, Dengfeng Cheng, Xinrong Liu, Shuping Dou

Bioorg Med Chem· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intraperitoneal injection is not always a suitable alternative to intravenous injection for radiotherapy.
Shuping Dou, Miles Smith, Yuzhen Wang, Mary Rusckowski, Guozheng Liu

Cancer Biother Radiopharm· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of Aspergillus fumigatus pulmonary fungal infections in mice with (99m)Tc-labeled MORF oligomers targeting ribosomal RNA.
Yuzhen Wang, Ling Chen, Xinrong Liu, Dengfeng Cheng, Guozheng Liu, Shuping Dou

Nucl Med Biol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pretargeting vs. direct targeting of human betalox5 islet cells subcutaneously implanted in mice using an anti-human islet cell antibody.
Guozheng Liu, Shuping Dou, Ali Akalin, Mary Rusckowski, Philip R Streeter

Nucl Med Biol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing the intracellular fate of components within a noncovalent streptavidin nanoparticle with covalent conjugation.
Yuxia Liu, Dengfeng Cheng, Xinrong Liu, Guozheng Liu, Shuping Dou

Nucl Med Biol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
9
90Y labeled phosphorodiamidate morpholino oligomer for pretargeting radiotherapy.
Guozheng Liu, Shuping Dou, Yuxia Liu, Yuzhen Wang, Mary Rusckowski

Bioconjug Chem· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing two TAG-72 binding peptides previously identified by phage display as potential imaging agents.
Ling Chen, Yi Wang, Dengfeng Cheng, Shuping Dou, Xinrong Liu

Nucl Med Commun· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving the quantitation accuracy in noninvasive small animal single photon emission computed tomography imaging.
Dengfeng Cheng, Mary Rusckowski, P Hendrik Pretorius, Ling Chen, Nan Xiao, Shuping Dou

Nucl Med Biol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human islet cell MORF/cMORF pretargeting in a xenogeneic murine transplant model.
Guozheng Liu, Shuping Dou, Dengfeng Cheng, Jean Leif, Mary Rusckowski

Mol Pharm· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reducing the background fluorescence in mice receiving fluorophore/inhibitor DNA duplexes.
Minmin Liang, Xinrong Liu, Guozheng Liu, Shuping Dou, Dengfeng Cheng

Mol Pharm· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unexpected side products in the conjugation of an amine-derivatized morpholino oligomer with p-isothiocyanate benzyl DTPA and their removal.
Guozheng Liu, Shuping Dou, Yuxia Liu, Minmin Liang, Ling Chen

Nucl Med Biol· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a high affinity TAG-72 binding peptide by phage display selection.
Nan Xiao, Dengfeng Cheng, Yi Wang, Ling Chen, Xinrong Liu, Shuping Dou

Cancer Biol Ther· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adding a clearing agent to pretargeting does not lower the tumor accumulation of the effector as predicted.
Guozheng Liu, Shuping Dou, Xiangji Chen, Ling Chen, Xinrong Liu

Cancer Biother Radiopharm· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A preclinical 188Re tumor therapeutic investigation using MORF/cMORF pretargeting and an antiTAG-72 antibody CC49.
Guozheng Liu, Shuping Dou, Stephen Baker, Ali Akalin, Dengfeng Cheng

Cancer Biol Ther· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preparation of (111)In-DTPA morpholino oligomer for low abdominal accumulation.
Guozheng Liu, Shuping Dou, Mary Rusckowski, Dale Greiner, Donald Hnatowich

Appl Radiat Isot· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Affinity enhancement pretargeting: synthesis and testing of a 99mTc-labeled bivalent MORF.
Jiang He, Yi Wang, Shuping Dou, Xinrong Liu, Surong Zhang

Mol Pharm· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multimodality nuclear and fluorescence tumor imaging in mice using a streptavidin nanoparticle.
Minmin Liang, Xinrong Liu, Dengfeng Cheng, Guozheng Liu, Shuping Dou

Bioconjug Chem· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ratio of maximum percent tumour accumulations of the pretargeting agent and the radiolabelled effector is independent of tumour size.
Guozheng Liu, Shuping Dou, Minmin Liang, Xiangji Chen, Mary Rusckowski

Eur J Cancer· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis